A novel targeted delivery system utilizing a cephalosporin-oncolytic prodrug activated by an antibody -lactamase conjugate for the treatment of cancer
Basic Information
ID: ALA1125938
Journal: Bioorg Med Chem Lett
Title: A novel targeted delivery system utilizing a cephalosporin-oncolytic prodrug activated by an antibody -lactamase conjugate for the treatment of cancer
Authors: Shepherd TA, Jungheim LN, Meyer DL, Starling JJ
DOI: 10.1016/S0960-894X(01)81083-0
Patent ID: ┄
Associated Items: Associated Bioactivities Associated Assays Associated Compounds Associated Targets